• About us
• Contact

Advertisement

Organisation › Details

Gilde Healthcare Venture&Growth VI fund

Gilde Healthcare in April 2023 announced a new investment fund with €600 million in commitments: Gilde Healthcare Venture&Growth VI. The new fund focuses on fast growing companies developing solutions for better care at lower cost. Gilde Healthcare invests in companies in Europe and North America active in digital healthcare, medical technology (MedTech) and therapeutics. The fund is backed by a balanced mix of international investors, including corporates, banks, pension funds, insurers, fund-of-funds, sovereign wealth funds, endowments, family offices, entrepreneurs and the Gilde team. The new fund will invest €10-60 million per new portfolio company. Together with the last Venture&Growth fund (closed in 2020) and Gilde Healthcare Private Equity IV (closed in 2022), Gilde Healthcare has raised €1.5 billion in capital over the last three years. *

 

	Start	2023-04-19 announced
	Group	Gilde Investment (Group)
	Person	van der Meer, Edward (Healthy Aging Campus Netherlands 201410 Managing Director)
	Region	Utrecht
	Country	Netherlands
	City	n. a.
		Address record changed: 2023-06-08
Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	600,000,000 (capital committed (2023) 2023-04-19)
		* Document for »About Section«: Gilde Healthcare Partners. (4/19/23). "Press Release: Gilde Healthcare Raises €600 Million to Invest in Healthcare innovation". Utrecht.
		Record changed: 2024-02-12

Advertisement

More documents for Gilde Investment (Group)

• [1] Gilde Healthcare Partners. (11/15/23). "Press Release: Gilde Healthcare Closes New Venture&Growth Fund at €740 Million Hard Cap". Utrecht....
• [2] Gilde Healthcare Partners. (6/9/23). "Press Release: Gilde Healthcare Strengthens Investor Relations and Fundraising Team with Besmire Ahmati". Utrecht....
• [3] Gilde Healthcare Partners. (4/19/23). "Press Release: Gilde Healthcare Raises €600 Million to Invest in Healthcare innovation". Utrecht....
• [4] Gilde Healthcare Partners. (7/12/22). "Press Release: Gilde Healthcare Bolsters Its Private Equity Team in Frankfurt Office". Utrecht & Frankfurt a. M.....
• [5] Synexa Life Sciences B.V.. (5/18/22). "Press Release: Synexa Life Sciences Announces Strategic Growth Plans and Strengthening of Its Executive Team". Leiden....
• [6] Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht....
• [7] Gilde Healthcare Partners. (6/2/21). "Press Release: Gilde Healthcare Appoints Joep Muijrers to Lead Investments in Public Markets". Utrecht....
• [8] Gilde Healthcare Partners. (5/6/21). "Press Release: Gilde Healthcare Acquires Majority Stake in Danish Drug Development Consultancy KLIFO to Support International Growth Ambitions". Utrecht & Copenhagen....
• [9] Gilde Healthcare Partners. (3/31/20). "Press Release: Gilde Healthcare Raises €416 Million ($450 Million) Venture and Growth Capital Fund". Utrecht & Cambridge, MA....
• [10] Calypso Biotech S.A.. (2/20/19). "Press Release: Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases". Amsterdam....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.